President, Chief Executive Officer, Vice-Presidebt of Research,
Dr. Julianna Lisziewicz co-founded Genetic Immunity in 1998 and has served as the President and Chief Executive Officer of Genetic Immunity since its founding.
In 1994, Dr. Lisziewicz co-founded the non-profit Research Institute for Genetic and Human Therapy (RIGHT) and directed its research and business affairs in the USA. RIGHT was focusing on the treatment of HIV/AIDS from multiple perspectives: virology, molecular biology, immunology and medicine. From 1990 to 1995, she was Head of the Antiviral Unit in the Laboratory of Tumor Cell Biology at the National Cancer Institute of the NIH in Bethesda, Maryland. While at NIH, she discovered and developed antisense oligonucleotide therapy and gene therapy for HIV/AIDS treatment.
In 2005, she was appointed as the Marie Curie Chair at the Semmelweis University Budapest. She received her Ph.D in molecular biology from the Max-Planck Institute (Goettingen, Germany) and two Masters of Science in Chemistry and Biochemistry from the Technical University (Budapest, Hungary). She has co-authored over 100 peer reviewed scientific publications.